Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eurofarma Mometasone vs Nasonex in Allergic Rhinitis
NCT01372865Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Jun 2012
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mometasone in allergic rhinitis (AR) (2 arms), sponsored by Eurofarma. Primary endpoint: Nasal Index Score at 4 weeks. Started Jun 2012; status: completed.
02
Drugs
mometasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01372865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01372865.